Research show t-PBM has a significant, beneficial effect on cognitive performance in young, healthy adults. Nine studies were examined, of which seven studies were performed on young, health subjects ages 17-24 and two were conducted on older normal subjects ages 49 and up.
This paper reports the results from the Elated-2 Pilot Trial. The study is comprised of 21 adult MDD patients age 18 to 65, who underwent twice weekly transcranial photobiomodulation (t-BPM) sessions for 8 weeks. The study finds subjects receiving t-PBM with NIR light showed greater improvement than the sham group that did not receive any light therapy.
Current treatments for depression have significant efficacy and side effect burden. This paper provides a comprehensive overview of years of research on a novel, safe approach called transcranial photobiomodulation (t-PBM) as a device-based treatment that is efficacious, well-tolerated and easy to use.